Diabetes to weight loss to heart defence: Ozempic and Mounjaro protect against strokes and heart attacks, finds study

Two of the world’s most widely used diabetes and weight-loss medications, Ozempic and Mounjaro, may be doing far more than helping people control blood sugar and shed weight. A new study published in Nature Medicine shows that these drugs are also linked to a significant drop in the risk of major cardiovascular events such as strokes and heart attacks. The findings come from researchers at the Technical University of Munich (TUM) and Harvard Medical School, who analysed real-world medical records to understand how these treatments perform in everyday clinical care. Although Ozempic and Mounjaro are well known for their impressive weight-loss effects, the study found that their heart benefits cannot be explained by weight changes alone. According to lead author Dr Nils Krüger, the pr